Captrust Financial Advisors Lowers Position in Option Care Health, Inc. (NASDAQ:OPCH)

Captrust Financial Advisors cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 32.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,224 shares of the company’s stock after selling 6,260 shares during the period. Captrust Financial Advisors’ holdings in Option Care Health were worth $307,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Barclays PLC increased its stake in shares of Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after purchasing an additional 199,454 shares in the last quarter. Diversify Wealth Management LLC increased its stake in shares of Option Care Health by 31.7% during the fourth quarter. Diversify Wealth Management LLC now owns 13,560 shares of the company’s stock valued at $325,000 after purchasing an additional 3,261 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Fort Washington Investment Advisors Inc. OH increased its stake in shares of Option Care Health by 6.2% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 943,300 shares of the company’s stock valued at $21,885,000 after purchasing an additional 54,830 shares in the last quarter. Finally, Sheets Smith Wealth Management increased its stake in shares of Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on OPCH. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lifted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Down 0.1%

OPCH opened at $33.07 on Wednesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm’s fifty day moving average is $33.09 and its 200 day moving average is $29.15. The stock has a market cap of $5.42 billion, a price-to-earnings ratio of 27.79, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the company earned $0.26 EPS. The business’s quarterly revenue was up 16.3% compared to the same quarter last year. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.